Stay updated on OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.2 to v3.6.3. This appears to be a minor maintenance/version-control update rather than a substantive change to the study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-04T08:08:54.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a backend release update. No visible changes to study details or page content are evident.
    Difference
    0.0%
    Check dated 2026-06-27T03:25:37.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    - Added user guidance sections: How to Read a Study Record, Common Questions, How to Join a Study, and a recruitment status note: 'No longer looking for participants'. - Updated revision/version label to v3.6.0 and adjusted the Intervention/Treatment heading formatting (from 'Intervention / Treatment').
    Difference
    0.4%
    Check dated 2026-06-12T16:32:18.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.4 to v3.5.5, indicating a routine backend/display update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-06-05T12:33:40.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The study record now shows that results have been posted for OP-1250, replacing prior results-submission statuses, and includes detailed study design, eligibility criteria, cohorts, outcomes, and links to associated documents.
    Difference
    3%
    Check dated 2026-05-15T05:37:47.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page footer now shows a newer ClinicalTrials.gov release revision identifier (“v3.5.3” instead of “v3.5.2”). This reflects a site/version update rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-04-23T21:57:42.000Z thumbnail image

Stay in the know with updates to OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.